文献速递新发突发、热带与寄生虫病

非洲重症疟疾儿童青蒿琥酯延迟性溶血:发生率、医学影响与预防

Post-artesunate Delayed Hemolysis in African Children With Severe Malaria: Incidence, Medical Impact and Prevention.
PubMed 文献 · Clin Infect Dis · 2025-01-01

在贝宁开展的前瞻性重症疟疾研究中,351例接受青蒿琥酯治疗的儿童中,76/332例(22.9%)发生青蒿琥酯延迟性溶血(PADH)。PADH患儿在D14至D28期间严重贫血和输血更频繁,随访期间住院和感染事件更多;入院后3天内接受2次输血者PADH发生率低于未输血者(12.5% vs 26.8%,P = .015)。

要点

  • 非洲重症疟疾儿童接受青蒿琥酯治疗后PADH发生率为22.9%(76/332)。
  • PADH患儿D14至D28严重贫血(10.6% vs 0.4%)和输血(9.8% vs 0%)更频繁。
  • 入院后3天内2次输血者PADH发生率低于未输血者(12.5% vs 26.8%,P = .015)。

核心结论

  • 尽管普遍存在抗疟药自我用药,PADH仍影响23%接受青蒿琥酯治疗的非洲重症疟疾儿童,其中超过15%出现严重贫血和/或感染事件。
  • 早期宽松输血可能对PADH具有保护作用。

研究设计与样本

  • 前瞻性重症疟疾研究,纳入贝宁351例接受青蒿琥酯治疗的儿童。
  • 采集入院时及开始治疗后第3、5、14、21、28天的临床、流行病学和生物学数据及抗疟药血浆浓度。
  • PADH定义为第5天以后血红蛋白水平下降>10%和/或LDH浓度升高>10%。

主要发现

  • 14例儿童(4%)在D14前死亡。
  • 10%的监护人称入院前曾给予抗疟药,316/350(90%)儿童血浆中可检出鲁美泛曲(n = 279)、奎宁(n = 104)、磺多辛(n = 67)、青蒿素类(n = 28)、氯喹(n = 16)或其他抗疟药(n = 9)的水平。
  • PADH发生于76/332例儿童(22.9%),这些儿童坑状红细胞水平更高且贫血恢复更慢。
  • D14至D28期间,PADH患儿较无PADH患儿严重贫血(10.6% vs 0.4%)和输血(9.8% vs 0%)更频繁。
  • 随访期间PADH患儿较无PADH患儿住院更频繁(11.1% vs 1.6%)且感染事件更多(6.9% vs 0.4%)。

临床怎么用

  • 作者认为早期宽松输血可能对PADH具有保护作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Post-artesunate delayed hemolysis (PADH) occurs in 7%-25% of adults with severe imported malaria. Whether it exists in African children is controversial. METHODS: In total, 351 children treated with artesunate were enrolled in a prospective severe malaria study in Benin. Clinical, epidemiological and biological data, plasma concentrations of antimalarials were captured or determined on admission then at 3, 5, 14, 21, and 28 days after starting treatment. PADH was defined by a >10% drop in hemoglobin level and/or a >10% rise in LDH concentrations beyond Day 5. RESULTS: Fourteen children (4%) died before D14. Although 10% of guardians declared administration of anti-malarial drugs before admission, 316/350 (90%) of children had measurable plasma levels of lumefantrine (n = 279), quinine (n = 104), sulfadoxine (n = 67), artemisinin (n = 28), chloroquine (n = 16), or other antimalarials (n = 9). PADH occurred in 76/332 children (22.9%). Levels of pitted red blood cells (RBC) were higher and recovery from anemia was slower in these children. Severe anemia and transfusion were more frequent between D14 and D28 in children with PADH compared to children without PADH (10.6% vs 0.4%, 9.8% vs 0%). During follow-up, children with PADH were more frequently hospitalized (11.1% vs 1.6%) and had more frequent infectious events (6.9% vs 0.4%) than children without PADH. Children who received 2 transfusions within 3 days post-admission had a lower incidence of PADH than untransfused children (12.5% vs 26.8%, P = .015). CONCLUSIONS: Despite widespread self-medication with antimalarials, PADH affects 23% of African children treated with artesunate for severe malaria, of whom more than 15% suffer from severe anemia and/or infectious events. Liberal early transfusion may be protective against PADH.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Carret V, Sossou D, Yakoubou A, et al. Post-artesunate Delayed Hemolysis in African Children With Severe Malaria: Incidence, Medical Impact and Prevention. Clin Infect Dis. 2025. PMID: 39964912. doi:10.1093/cid/ciaf067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。